OpenAI’s GPT-5, in collaboration with Ginkgo Bioworks‘ cloud automation, has achieved a 40% reduction in cell-free protein synthesis costs. This was accomplished through closed-loop experimentation in an autonomous lab, showcasing AI’s impact on biotech efficiency.
Source: OpenAI